R&D | May 25, 2026
AstraZeneca to showcase cancer pipeline push at ASCO 2026
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
Access to genomic testing, not therapy cost, is the biggest challenge
Paves way for CNS cancer test rollout
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
Hospital project inaugurated by Devendra Fadnavis aims to strengthen healthcare access across North Maharashtra and nearby regions
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
The company says the platform offers improved manufacturability and functional advantages
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
